Skip to main content
Caplight Logo









Speetar

Speetar

Private
Brookline, MassachusettsHealthcare & Life Scienceshttps://speetar.com/

Last Round

Grant

Jun 27, 2023

Total Funding Raised

$300,000

Company Overview

Speetar operates in Healthcare & Life Sciences and is based in Brookline, Massachusetts. Its latest recorded funding round was a Grant round in June 2023.

Speetar is a healthtech company that provides a telehealth platform connecting patients in conflict-affected and underserved regions with medical professionals.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Speetar Comparables

Compare Speetar with similar companies based on industry and business-model similarity.

Speetar comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MyUSADr.
77%
Altibbi
76%
Amwell
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Speetar Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 27, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Speetar Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 6, 2025

    Grew 43% QoQ, from 7 to 10 employees.

  • Jul 23, 2025

    Grew 100% QoQ from 3 to 6 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Speetar Filings

Explore SEC and related filing metadata, where available.

Speetar filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Speetar's valuation, stock price, and market status.

Is Speetar a public or private company?

Speetar is a private company.

What is the current stock price of Speetar?

Speetar is a private company, so its shares have no public market price. Caplight tracks Speetar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Speetar worth (valuation)?

Valuation information for Speetar is not publicly available.

Can I buy Speetar stock?

Speetar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Speetar's last funding round?

Speetar's most recent funding round was Grant on June 27, 2023.

Who are the main investors in Speetar?

Key investors in Speetar include Seedstars, Echoing Green, Humanitarian Grand Challenge, MIT Sandbox Innovation Fund.

Will Speetar IPO soon?

No public IPO plans have been announced for Speetar.

How can I track Speetar secondary market activity?

Caplight tracks bids, offers, and trades in Speetar's shares on secondary markets.

Firmographic Details

HeadquartersBrookline, Massachusetts
Employee Range10
Year Founded2019
Last FundingJun 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?